COVID-19 impact on blood donor characteristics and seroprevalence of transfusion-transmitted infections in southern Thailand between 2018 and 2022

Sci Rep. 2024 Apr 4;14(1):7920. doi: 10.1038/s41598-024-57584-z.

Abstract

Blood safety is a critical aspect of healthcare systems worldwide involving rigorous screening, testing, and processing protocols to minimize the risk of transfusion-transmitted infections (TTIs). The present study offers a comprehensive assessment of the prevalence of hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), and syphilis among blood donors in southern Thailand. It explores the consequences of the COVID-19 pandemic on the blood transfusion service, donor characteristics, and the prevalence of TTIs. A retrospective analysis of 65,511 blood donors between 2018 and 2022 was conducted at Songklanagarind Hospital, Thailand. The socio-demographic characteristics of the donors were examined using the Chi-square test to assess the relationship between TTIs serological positivity and donor characteristics. The donors were divided into pre-COVID-19 (2018-2019) and during COVID-19 (2020-2022) groups to evaluate the impacts of COVID-19. The study found that HBV had the highest overall prevalence at 243 per hundred thousand (pht), followed by syphilis (118 pht), HCV (32 pht), and HIV (31 pht) over a five-year period of study. After COVID-19, the prevalence of HBV decreased by 21.8%; HCV decreased by 2.1%; HIV increased by 36.4%; and syphilis increased by 9.2%. The socio-demographic characteristics and TTIs prevalence were significantly altered over time. This study provides insights into blood donor characteristics and TTIs prevalence in southern Thailand, highlighting the understanding of the impact of COVID-19 on the spread of TTIs.

Keywords: Blood donation; HBV; HCV; HIV; Syphilis; Transfusion.

MeSH terms

  • Blood Donors
  • COVID-19* / epidemiology
  • HIV Infections* / diagnosis
  • HIV Infections* / epidemiology
  • Hepatitis B* / diagnosis
  • Hepatitis B* / epidemiology
  • Hepatitis C* / diagnosis
  • Hepatitis C* / epidemiology
  • Humans
  • Pandemics
  • Retrospective Studies
  • Seroepidemiologic Studies
  • Syphilis* / epidemiology
  • Thailand / epidemiology
  • Transfusion Reaction*